Phase II Apa-RP Study of Erleada Shows Promise in Treatment of Patients with High-Risk Localized Prostate Cancer Who Have Undergone Previous Radical Prostatectomy

admin
Estimated read time 1 min read

Significant findings included a 100% biochemical recurrence-free rate at 24 months post-surgery in patients with high-risk localized prostate cancer.

Avatar for admin
admin https://bliolm.com

You May Also Like

More From Author

+ There are no comments

Add yours